CRISPR

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.

CEO

Samarth Kulkarni

CEOSamarth Kulkarni

Employees

407

Employees407

Headquarters

Zug, Zug

HeadquartersZug, Zug

Founded

2013

Founded2013

Employees

407

Employees407

CRSP Key Statistics

Market cap

3.51B

Market cap3.51B

Price-Earnings ratio

-14.55

Price-Earnings ratio-14.55

Dividend yield

—

Dividend yield—

Average volume

1.96M

Average volume1.96M

High today

—

High today—

Low today

—

Low today—

Open price

$40.21

Open price$40.21

Volume

641.00

Volume641.00

52 Week high

$91.10

52 Week high$91.10

52 Week low

$39.41

52 Week low$39.41

Analyst ratings

52%

of 31 ratings

Buy

51.6%

Hold

41.9%

Sell

6.5%